All In Biotech

Drug Trial Radar · NCT01849926

Ibuprofen Versus Mecillinam for Uncomplicated Cystitis

Ibuprofen Versus Mecillinam for Uncomplicated Cystitis in Adult, Non-pregnant Women

Last checked: Nov 20, 2026Latest source record: Nov 6, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 383 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

383

Actual

Start

Apr 2013

Primary completion

Jul 2016

Study completion Jul 2016

Sponsor

Lead sponsor
University of OsloAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Bergen; Lund University; University of Copenhagen
First posted
May 9, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Although uncomplicated cystitis is considered to be a mild condition and mostly self limiting, most patients who see a doctor will be treated with antibiotics. Antibiotics are known to give a quick relief of symptoms and shorten the course of the condition by a few days. The aim of this study is to evaluate ibuprofen versus mecillinam in the treatment of uncomplicated cystitis in otherwise healthy, non-pregnant women. Our main objective is to see whether symptomatic treatment with ibuprofen is equally efficient as treatment with mecillinam in this group.

Conditions

  • Acute Cystitis (Excl in Pregnancy)

Interventions

  • IbuprofenDrug

  • MecillinamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients who are symptom free by day fourTime frame: Four days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Oslo

    Oslo, Norway

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.